Interestingly, miR-137 levels significantly, but conversely, correlated with ASCT2 in multiple cancer types, including colorectal carcinoma, glioblastoma, prostate and pancreatic cancers (Figure 3d–g). Here, SLC1A5 is linked to glioblastoma.